Welcome to CSL’s Open Innovation Submission Portal
CSL is a leading global biotech company that develops and delivers innovative biotherapies that help people with life-threatening medical conditions live full lives. Innovation has been in CSL’s DNA for more than a century. CSL has the full spectrum of strengths from research and clinical development to manufacturing and commercialization across six therapeutic areas of expertise. Their strengths enable them to accurately identify, successfully develop, and dependably deliver innovations for patients.
At CSL they believe that for innovation to be fast tracked, they need to partner with the brightest minds in the sector. They know that partnerships can accelerate innovation and delivery of new life-saving and protective medicines and they collaborate and work with external organizations that have unique technologies, assets and equipment, to address patients’ unmet needs around the globe.
If you have an idea related to new products, new technologies or new advancements relating to CSL’s areas of interest, please feel free to share it via the Submission Form. All submissions will be screened by yet2 and if successful, will be shared with CSL. Initial submissions should not include any confidential information.
Core interests for early stage partnering
New infectious disease vaccine targets
- Respiratory pathogens a priority
- New antigenic vaccine targets without current treatments
- Methods (e.g. AI/machine learning) to predict viral evolution/pathogenicity to inform vaccine development
- New approaches to routes of administration
- New ambient stability technology for vaccines (protein)
- RNA delivery, enhanced stability, route of administration and/or expression strategies
- mRNA cellular targeting technologies
Immune mechanisms and delivery
- Modulating innate and/or adaptive responses to vaccines
Click each linked title to submit your solution for each need.
Image by Freepik